EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,472 press releases posted in the last 24 hours and 358,535 in the last 365 days.

Press Releases on January 4, 2023

1,402 Press Releases

Published on January 4, 2023 - 12:05 GMT

Aravive Announces Complete Enrollment in the Global Registrational Phase 3 AXLerate-OC Trial for Platinum-Resistant Ovarian Cancer

Topline data expected mid-2023 Potential Biologics License Application (BLA) submission end of 2023 HOUSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, the “Company”), a late clinical-stage oncology company developing targeted …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:02 GMT

Riverside’s Exit of SureWerx is a Sure Success for Everyone Involved

CLEVELAND, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The Riverside Company, a global private investor focused on the smaller end of the middle market, has sold its investment in SureWerx, a leading North American provider of personal protective equipment, safety …

Distribution channels:
Published on January 4, 2023 - 12:02 GMT

Fulcrum Therapeutics Provides Business Update and 2023 Outlook

― FTX-6058 granted Fast Track Designation for sickle cell disease (SCD) from FDA in December 2022 ― ― Completed enrollment in 6 mg and 2 mg dose cohorts of the Phase 1b trial of FTX-6058 in SCD; enrollment ongoing in 12 mg dose cohort ― ― Additional FTX- …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:01 GMT

Nurix Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:01 GMT

Fulcrum Therapeutics Announces CEO Transition

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that Robert J. …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:01 GMT

Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on January 4, 2023 - 12:00 GMT

BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:00 GMT

Arvinas to Present at 41st Annual J.P. Morgan Healthcare Conference

NEW HAVEN, Conn., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that John Houston, Ph.D., President and Chief …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:00 GMT

Sterling Acquires Socrates Ltd., Latin America’s Largest Independent Background Screening Company

NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Sterling Check Corp. (NASDAQ: STER) (“Sterling”), a leading global provider of background screening and identity services, today announced that it has acquired Socrates Ltd. (“Socrates”), the largest independent …

Distribution channels: Companies, Technology ...
Published on January 4, 2023 - 12:00 GMT

Sterling adquiere Socrates Ltd., la mayor empresa independiente de verificación de antecedentes de América Latina

NUEVA YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Sterling Check Corp. (NASDAQ: STER) (“Sterling”), un proveedor líder mundial de servicios de verificación de antecedentes e identidad, anunció hoy que adquirió Socrates Ltd. (“Sócrates”), la mayor empresa de …

Distribution channels: Companies, Technology ...
Published on January 4, 2023 - 12:00 GMT

Sterling Adquire Sócrates Ltd., a Maior Empresa de Verificação de Antecedentes Independente da América Latina

NOVA YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- A Sterling Check Corp. (NASDAQ: STER) (“Sterling”), fornecedora líder global de serviços de verificação de antecedentes e identidade, anunciou hoje que adquiriu a Socrates Ltd. (“Socrates”), a maior empresa de …

Distribution channels: Companies, Technology ...
Published on January 4, 2023 - 12:00 GMT

Investment Crowdfunding Stumbled in 2022 - Investors Pull Back as more Sophisticated Companies Seek Capital Online

A forthcoming report by Crowdfund Capital Advisors tracks how the economic, social, and geopolitical turmoil of 2022 spilled over to Investment Crowdfunding DENVER, CO, UNITED STATES, January 4, 2023 /⁨EINPresswire.com⁩/ -- In its upcoming report “What a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on January 4, 2023 - 12:00 GMT

TierOne announces transition to a digital workplace

TierOne is moving to a new physical office with virtual-office options. It will facilitate future growth and expansion of the business. MISSISSAUGA, ONTARIO, CANADA, January 4, 2023 /⁨EINPresswire.com⁩/ -- TierOne is excited to announce that it will be …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on January 4, 2023 - 12:00 GMT

Alternative Medicine Launches New Focus Center On Website

All-natural health magazine invites holistic enthusiasts to visit their Focus Center. EAGAN, MN, UNITED STATES, January 4, 2023 /⁨EINPresswire.com⁩/ -- Holistic and natural wellness solutions magazine, Alternative Medicine is thrilled to announce a new …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:00 GMT

Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference

Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 04 January 2023) Immunocore Holdings Plc (Nasdaq: IMCR), a commercial-stage biotechnology company …

Distribution channels: Technology
Published on January 4, 2023 - 12:00 GMT

CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability

PRESS RELEASE CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability Enhanced leadership team brings strong AI and drug discovery expertise and experience, reinforcing CHARM Therapeutics’ …

Distribution channels: Technology
Published on January 4, 2023 - 12:00 GMT

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

PHILADELPHIA, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that Lalo Flores, Ph.D., …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on January 4, 2023 - 12:00 GMT

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and …

Distribution channels:
Published on January 4, 2023 - 12:00 GMT

Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel

FDA Approval Currently Expected by Mid-2023 Sales of CYTOGAM® Highest Among Four IgG Products Acquired in November 2021, with Gross Margins Over 50% Ability to Manufacture CYTOGAM at Kamada’s Facility to Positively Impact Plant Utilization and Efficiency …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on January 4, 2023 - 12:00 GMT

Atea Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

BOSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals, will …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Previous 40 41 42 43 44 45 46 47 48 49 50 Next

Previous Day 2023 Calendar Next Day